14-hydroxydocosahexaenoate and Disease-Models--Animal

14-hydroxydocosahexaenoate has been researched along with Disease-Models--Animal* in 3 studies

Other Studies

3 other study(ies) available for 14-hydroxydocosahexaenoate and Disease-Models--Animal

ArticleYear
Disruption of pulmonary resolution mediators contribute to exacerbated silver nanoparticle-induced acute inflammation in a metabolic syndrome mouse model.
    Toxicology and applied pharmacology, 2021, 11-15, Volume: 431

    Pre-existing conditions modulate sensitivity to numerous xenobiotic exposures such as air pollution. Specifically, individuals suffering from metabolic syndrome (MetS) demonstrate enhanced acute inflammatory responses following particulate matter inhalation. The mechanisms associated with these exacerbated inflammatory responses are unknown, impairing interventional strategies and our understanding of susceptible populations. We hypothesize MetS-associated lipid dysregulation influences mediators of inflammatory resolution signaling contributing to increased acute pulmonary toxicity. To evaluate this hypothesis, healthy and MetS mouse models were treated with either 18-hydroxy eicosapentaenoic acid (18-HEPE), 14-hydroxy docosahexaenoic acid (14-HDHA), 17-hydroxy docosahexaenoic acid (17-HDHA), or saline (control) via intraperitoneal injection prior to oropharyngeal aspiration of silver nanoparticles (AgNP). In mice receiving saline treatment, AgNP exposure resulted in an acute pulmonary inflammatory response that was exacerbated in MetS mice. A targeted lipid assessment demonstrated 18-HEPE, 14-HDHA, and 17-HDHA treatments altered lung levels of specialized pro-resolving lipid mediators (SPMs). 14-HDHA and 17-HDHA treatments more efficiently reduced the exacerbated acute inflammatory response in AgNP exposed MetS mice as compared to 18-HEPE. This included decreased neutrophilic influx, diminished induction of inflammatory cytokines/chemokines, and reduced alterations in SPMs. Examination of SPM receptors determined baseline reductions in MetS mice compared to healthy as well as decreases due to AgNP exposure. Overall, these results demonstrate AgNP exposure disrupts inflammatory resolution, specifically 14-HDHA and 17-HDHA derived SPMs, in MetS contributing to exacerbated acute inflammatory responses. Our findings identify a potential mechanism responsible for enhanced susceptibility in MetS that can be targeted for interventional therapeutic approaches.

    Topics: Animals; Anti-Inflammatory Agents; Cytokines; Diet, High-Fat; Disease Models, Animal; Docosahexaenoic Acids; Gene Expression Regulation; Hydroxyeicosatetraenoic Acids; Inflammation Mediators; Lipid Metabolism; Lung; Male; Metabolic Syndrome; Metal Nanoparticles; Mice, Inbred C57BL; Pneumonia; Signal Transduction; Silver Compounds

2021
Frontline Science: A reduction in DHA-derived mediators in male obesity contributes toward defects in select B cell subsets and circulating antibody.
    Journal of leukocyte biology, 2019, Volume: 106, Issue:2

    Topics: Animals; Antibodies; B-Lymphocyte Subsets; Biomarkers; Bone Marrow Cells; Diet, High-Fat; Disease Models, Animal; Disease Susceptibility; Docosahexaenoic Acids; Female; Germinal Center; Humans; Immunophenotyping; Inflammation Mediators; Lipid Metabolism; Lymphocyte Activation; Lymphocyte Count; Male; Metabolomics; Mice; Mice, Knockout; Mice, Obese; Obesity; Phenotype; Sex Factors

2019
B Cell Activity Is Impaired in Human and Mouse Obesity and Is Responsive to an Essential Fatty Acid upon Murine Influenza Infection.
    Journal of immunology (Baltimore, Md. : 1950), 2017, 06-15, Volume: 198, Issue:12

    Obesity is associated with increased risk for infections and poor responses to vaccinations, which may be due to compromised B cell function. However, there is limited information about the influence of obesity on B cell function and underlying factors that modulate B cell responses. Therefore, we studied B cell cytokine secretion and/or Ab production across obesity models. In obese humans, B cell IL-6 secretion was lowered and IgM levels were elevated upon ex vivo anti-BCR/TLR9 stimulation. In murine obesity induced by a high fat diet, ex vivo IgM and IgG were elevated with unstimulated B cells. Furthermore, the high fat diet lowered bone marrow B cell frequency accompanied by diminished transcripts of early lymphoid commitment markers. Murine B cell responses were subsequently investigated upon influenza A/Puerto Rico/8/34 infection using a Western diet model in the absence or presence of docosahexaenoic acid (DHA). DHA, an essential fatty acid with immunomodulatory properties, was tested because its plasma levels are lowered in obesity. Relative to controls, mice consuming the Western diet had diminished Ab titers whereas the Western diet plus DHA improved titers. Mechanistically, DHA did not directly target B cells to elevate Ab levels. Instead, DHA increased the concentration of the downstream specialized proresolving lipid mediators (SPMs) 14-hydroxydocosahexaenoic acid, 17-hydroxydocosahexaenoic acid, and protectin DX. All three SPMs were found to be effective in elevating murine Ab levels upon influenza infection. Collectively, the results demonstrate that B cell responses are impaired across human and mouse obesity models and show that essential fatty acid status is a factor influencing humoral immunity, potentially through an SPM-mediated mechanism.

    Topics: Animals; B-Lymphocytes; Diet, Western; Disease Models, Animal; Docosahexaenoic Acids; Fatty Acids, Essential; Humans; Immunity, Humoral; Immunoglobulin M; Influenza A virus; Interleukin-6; Lymphocyte Activation; Mice; Obesity; Orthomyxoviridae Infections; Toll-Like Receptor 9

2017